Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 632

2.

Allele-specific and peptide-dependent recognition of swine leukocyte antigen class I by human cytotoxic T-cell clones.

Xu XC, Naziruddin B, Sasaki H, Smith DM, Mohanakumar T.

Transplantation. 1999 Aug 27;68(4):473-9.

PMID:
10480402
3.

Recognition of porcine major histocompatibility complex class I antigens by human CD8+ cytolytic T cell clones.

Shishido S, Naziruddin B, Howard T, Mohanakumar T.

Transplantation. 1997 Jul 27;64(2):340-6.

PMID:
9256198
4.

Induction of swine major histocompatibility complex class I molecules on porcine endothelium by tumor necrosis factor-alpha reduces lysis by human natural killer cells.

Kwiatkowski P, Artrip JH, John R, Edwards NM, Wang SF, Michler RE, Itescu S.

Transplantation. 1999 Jan 27;67(2):211-8.

PMID:
10075583
5.

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.

Jäger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A.

J Exp Med. 1998 Jan 19;187(2):265-70.

6.

Porcine endogenous retrovirus encodes xenoantigens involved in porcine cellular xenograft rejection by mice.

Simeonovic CJ, Ziolkowski AF, Popp SK, Milburn PJ, Lynch CA, Hamilton P, Harris K, Brown DJ, Bain SA, Wilson JD, Gibbs AJ.

Transplantation. 2005 Jun 27;79(12):1674-82.

PMID:
15973168
7.

Tissue-specific peptides influence human T cell repertoire to porcine xenoantigens.

Xu XC, Howard T, Mohanakumar T.

Transplantation. 2001 Oct 15;72(7):1205-12.

PMID:
11602843
8.

Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.

Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J.

J Natl Cancer Inst. 1995 Jul 5;87(13):982-90.

PMID:
7629885
10.

Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.

Kurokohchi K, Akatsuka T, Pendleton CD, Takamizawa A, Nishioka M, Battegay M, Feinstone SM, Berzofsky JA.

J Virol. 1996 Jan;70(1):232-40.

11.

HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity.

Sasaki H, Xu XC, Smith DM, Howard T, Mohanakumar T.

Transplantation. 1999 Jan 15;67(1):31-7.

PMID:
9921792
13.

Identification of melanoma-specific peptide epitopes by HLA-A2.1-restricted cytotoxic T lymphocytes.

Ge HL, Wang Y, Wang SJ, Zhang Y.

Acta Biochim Biophys Sin (Shanghai). 2006 Feb;38(2):110-8.

14.

Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLA-A2-restricted cytotoxic T cells.

Ramakrishna V, Ross MM, Petersson M, Gatlin CC, Lyons CE, Miller CL, Myers HE, McDaniel M, Karns LR, Kiessling R, Parmiani G, Flyer DC.

Int Immunol. 2003 Jun;15(6):751-63.

PMID:
12750359
15.

HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.

Wizel B, Houghten R, Church P, Tine JA, Lanar DE, Gordon DM, Ballou WR, Sette A, Hoffman SL.

J Immunol. 1995 Jul 15;155(2):766-75.

PMID:
7541824
16.

Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.

Bondurant KL, Crew MD, Santin AD, O'Brien TJ, Cannon MJ.

Clin Cancer Res. 2005 May 1;11(9):3446-54.

17.
18.

Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma.

Bernhard H, Maeurer MJ, Jäger E, Wölfel T, Schneider J, Karbach J, Seliger B, Huber C, Storkus WS, Lotze MT, Meyer zum Büschenfelde KH, Knuth A.

Scand J Immunol. 1996 Sep;44(3):285-92.

PMID:
8795723
19.

Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.

Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C.

Hepatology. 2001 Jun;33(6):1533-43.

PMID:
11391544
20.

Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant.

McArdle SE, Rees RC, Mulcahy KA, Saba J, McIntyre CA, Murray AK.

Cancer Immunol Immunother. 2000 Oct;49(8):417-25.

PMID:
11043848
Items per page

Supplemental Content

Support Center